Seroprevalence of varicella antibodies in unvaccinated children with nephrotic syndrome in disease remission
Authors:
Open Access
- 15 September 2026
- journal article
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 164 (4) , 647-651
Abstract
Background and objectives: Varicella-zoster (VZV) virus infection can be severe in children with nephrotic syndrome. Lack of varicella vaccination through the national immunisation programme in India leaves many vulnerable to infection. We conducted this study to document the seroprevalence of Varicella antibodies in patients with nephrotic syndrome. Methods: This cross-sectional study (Oct 2024-May 2025) was conducted at a tertiary-care teaching hospital in India, in children (1-18 y) with nephrotic syndrome (both steroid-sensitive and steroid-resistant) in disease remission. Serum VZV IgG antibodies were measured using the EUROIMMUN ELISA kit; titres ≥100 IU/L were considered seroprotective. Results: 100 patients were enrolled (median age 8 y). None had received varicella vaccination, and only two reported prior infection. Overall seroprotection was 22% with a geometric mean titre of 9.472 IU/L [median (IQR) 7.59 (3.35; 73.38) IU/L]. No significant difference was observed in titres between steroid-sensitive and steroid-resistant nephrotic syndrome ( P =0.532), but seroprotection increased with age (11.1% in 10 y). Interpretation and conclusions: Low seroprevalence likely reflects the inadequacy of natural immunity and absence of routine varicella vaccination, warranting larger seroprevalence studies and future research on the need for priority immunisation for this high-risk population.Keywords
This publication has 20 references indexed in Scilit:
- Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis, Treatment, and PreventionMedcomm, 2026
- Steroid Sensitive Nephrotic Syndrome: Revised GuidelinesIndian Pediatrics, 2021
- Seroprevalence of vaccine-preventable diseases among children and adolescents in Singapore: Results from the National Paediatric Seroprevalence Survey 2018International Journal of Infectious Diseases, 2020
- Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive AgentsThe Journal of Pediatrics, 2018
- A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence dataEpidemiology and Infection, 2017
- Seroepidemiology of varicella among elementary school children in northern TaiwanJournal of Microbiology, Immunology and Infection, 2017
- Varicella zoster virus infectionNature Reviews Disease Primers, 2015
- Changing seroprevalence of varicella zoster virus infection in a tropical city state, SingaporeInternational Journal of Infectious Diseases, 2014
- Seroprotection for hepatitis B in children with nephrotic syndromePediatric Nephrology, 2013
- Varicella vaccination in children with steroid-sensitive nephrotic syndromePediatric Nephrology, 2002